CXO Intelligence Series · Sub-series

Life Sciences Series

AI in FDA and EMA regulated environments, where a decision can reach a patient.

This track covers AI where the regulator is already in the room: computer system validation and continuous assurance, ALCOA+ data integrity, GAMP 5, 21 CFR Part 11 and EU Annex 11, and what it takes for a model that learns to be provable rather than merely accurate.

1 published · ISSN: applied for · Bengaluru, India

Enterprise AI Series Governance Series Life Sciences Series

The track

Every piece, in order of publication

  • The Frontier Model Dilemma: Why Governance, Not Model Choice, Determines Regulatory Defensibility Edition 01 8 August 2026 HTML

This is a sub-series, not a separate publication. The Life Sciences Series is one named track inside the CXO Intelligence Series, an independent, weekly AI thought leadership journal for the C-suite on building the AI-native enterprise. It is vendor-neutral and published from Bengaluru. Journal particulars, the full archive and the road ahead are on the series page.

Journal particulars and full archive See these in the article index